Paul Rothman, MD, CEO of Baltimore-based Johns Hopkins Medicine and dean of the medical faculty at Johns Hopkins University, discussed the health system's COVID-19 data platform and the potential for artificial intelligence to make a difference in how health systems approach treatment in the future in an interview with The Media Line.
Since the pandemic began, Johns Hopkins has gathered COVID-19 data and reported it on a public dashboard for cases and deaths in the U.S. and across the world. Dr. Rothman said the health system is using artificial intelligence and machine learning in its platform and aims to collaborate with others to incorporate data in the future.